CLPT vs VTAK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VTAK Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Catheter Precision, Inc. (VTAK) driven by superior Growth & Margin, Options & Structure while CLPT counters with relative strength in Valuation, Momentum & Technical. Fundamentally, CLPT trades at 12.1x Forward P/E with -66.6% operating margin (+36.3% YoY revenue) versus VTAK at N/M Forward P/E and -388.1% operating margin (+380.7% YoY). In options structure, CLPT sits in BREAKDOWN (2nd %ile IV; Dealer Gamma Walls on Pro) against VTAK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CLPT Revenue | VTAK Revenue | CLPT Op. Margin | VTAK Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $10M | $10M | -71.4% | -498.0% | CLPT |
| FY2019 | $10M | $10M | -41.0% | -801.9% | CLPT |
| FY2020 | $10M | $0M | -48.5% | -13668.3% | CLPT |
| FY2021 | $20M | $0M | -82.1% | -133027.3% | CLPT |
| FY2022 | $20M | $0M | -79.5% | -192578.6% | CLPT |
| FY2023 | $20M | $0M | -93.7% | -17674.0% | CLPT |
| FY2024 | $30M | $0M | -62.9% | -2676.9% | CLPT |
| FY2025 | $40M | $0M | -65.4% | -2581.6% | CLPT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CLPT | VTAK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $271.8M | $548,639 | Larger Scale | CLPT |
| Trailing P/E Ratio Valuation | 12.1x | N/M | Lower Multiple | CLPT |
| Forward P/E Ratio Valuation | 12.1x | N/M | Lower Multiple | CLPT |
| Revenue Growth (YoY) Growth | +36.3% | +380.7% | Higher Growth | VTAK |
| Operating Margin (TTM) Profitability | -66.6% | -388.1% | Higher Margin | CLPT |
| Net Profit Margin Profitability | -79.4% | 0.0% | Higher Margin | VTAK |
| Return on Equity (ROE) Capital Efficiency | -167.5% | -111.3% | Higher ROE | VTAK |
| 52-Week Range Position Momentum | 2% ($8โ$20) | 1% ($0โ$3) | Stronger Trend | CLPT |
| Beta / 30D Volatility Risk Regime | 1.90ฮฒ ยท 85% Vol | 0.19ฮฒ ยท 76% Vol | Lower Realized Risk | VTAK |
| Unified Institutional Score Composite Signal | 40.0 / 100 (SELL) | 58.1 / 100 (HOLD) | Higher Composite | VTAK |